Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golexanolone in Primary Biliary Cholangitis (PBC) with Fatigue and Cognitive Dysfunction
NCT07304843Phase 2Completed
- Sponsor
- Umecrine Cognition
- Start
- Apr 2023
- Primary completion
- Sep 2026
- Modality
- Allosteric Modulators
- Countries
- 8
01
Overview
A Phase 2 trial of golexanolone in primary biliary cholangitis (PBC), sponsored by Umecrine Cognition. Started Apr 2023; status: completed.
02
Drugs
golexanolone
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT07304843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07304843.